Primary Prevention of Cardiovascular Disease
نویسندگان
چکیده
منابع مشابه
Statins for Primary Prevention of Cardiovascular Disease.
The US Preventive Services Task Force has recently recommended the use of statins in primary prevention of cardiovascular disease in adults. Doubts remain as to whether this approach is really cost-effective, and additional drawbacks include the increasing burden of potential side effects and incremental costs due to laboratory monitoring.
متن کاملPrimary Prevention of Occlusive Cardiovascular Disease
The synthesis of aspirin in the late nineteenth century marked the development of what was to become the most widely used household analgesic in the twentieth century. However, with the increased understanding of the major role of platelets in vascular occlusion over the last ten years, the importance of aspirin as an antiplatelet drug and, consequently, its applications in reducing the risks o...
متن کاملAspirin for primary prevention of cardiovascular disease
Cardiovascular disease (CVD) is a leading cause of mortality.1 For example, in 2000, it accounted directly for around 2 million deaths in the European Union.2 Worldwide, many people take aspirin daily in the belief that doing so helps to prevent CVD. This approach is established for the secondary prevention of recurrent vascular events. However, there has been some uncertainty about the place o...
متن کاملThe Use of Aspirin in Primary Prevention of Cardiovascular Disease.
The use of aspirin to prevent future cardiovascular events in those with a prior history of cardiovascular disease is recommended by all relevant guidelines and is supported by a strong evidence base. However, there has been much publicity and debate resulting from recent reports questioning the benefits of aspirin use in those with no history of prior cardiovascular disease, including those wi...
متن کاملStatins for the Primary Prevention of Cardiovascular Disease in Women
In this issue of Circulation, Mora et al demonstrate for the first time that statins are effective for the primary prevention of cardiovascular events in women.1 Under a prespecified analysis, the authors examined sex-specific outcomes in JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin), which enrolled 6801 women 60 years old and 11 001...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2002
ISSN: 0009-7322,1524-4539
DOI: 10.1161/01.cir.0000048067.86569.e1